DOCSLIB.ORG

Appendix J 2 3 References and Sources for Chapter Five – Screening and Testing 4 5 Table of Contents 6

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Appendix J 2 3 References and Sources for Chapter Five – Screening and Testing 4 5 Table of Contents 6 EDSTAC Final Report Chapter Five Appendices August 1998 1 Appendix J 2 3 References and Sources for Chapter Five – Screening and Testing 4 5 Table of Contents 6 I. Mammalian In Vitro and In Vivo Assays (Recommended and Considered) ........... 1 II. Fish Gonadal Recrudescence Assay .........................................10 III. Alternative Mammalian Reproduction Test .................................11 IV. Avian Reproduction (EPA OPPTS 850.2300; OECD 206) ......................11 V. Nest Attentiveness/Incubation Behavior Test References to be Used for Protocol Development and Standardization ............................................12 VI. Visual Cliff Test References to be Used for Protocol Development and Standardizatio12n VII. Cold Stress References to be Used for Protocol Development and Standardization . 12 VIII. Fish Life Cycle Test ...................................................13 IX. Methods to Select the Target Doses for T2T .................................13 X. Low Dose Consideration for T2T ........................................... 13 XI. Documents Distributed to Screening and Testing Work Group Members .......... 14 EDSTAC Final Report Chapter Five Appendices August 1998 Mammalian In Vitro and In Vivo Assays (Recommended and I. Considered) Aakvaag A., E. Utaaker, T. Thorsen, O.A. Lea, and H. Lahooti, “Growth control of human mammary cancer cells (MCF-7 cells) in culture: effect of estradiol and growth factors in serum-containing medium,” Cancer Research, 50, 1990, pp. 7806-10. Aitken S.C., M.E. Lippman , A. Kasid, and D.R. Schoenberg, “Relationship between the expression of estrogen-regulated genes and estrogen-stimulated proliferation of MCF-7 mammary tumor cells,” Cancer Research, 45, 1985, pp. 2608-15. Allegretto, E., and R. Heyman, “Intracellular Receptor Characterization And Ligand Screening By Transactivation And Hormone-Binding Assays,” Methods in Molecular Genetics, 8, 1996, pp. 405-420. Allen, E., and E. Doisy, “The induction of a sexually mature condition in immature females by injection of the ovarian follicular hormone,” American Journal of Physiology 69, 1924, pp. 577. Arai, Y., T. Mori, Y. Suzuki, and Bern, “Long-term effects of perinatal exposure to sex steroids and diethylstilbestrol on the reproductive system of male mammals,” International Review of Cytology, 84, 1983, pp. 235-268. Armstrong, D. T., J.H. Dorrington, J. Robinson, “Effects of indomethacin and aminoglutethimide phosphate in vivo on luteinizing-hormone-induced alterations of cyclic adenosine monophosphate, prostaglandin F, and steroid levels in preovulatory rat ovaries,” Canadian Journal Biochemistry, 54, 1976, pp. 796-802. Arnold, S. F., D.M. Klotz, B.M. Collins, P.M. Vonier, L.J. Guillette, and J.A. Mclachlan, “Synergistic activation of estrogen receptor with combinations of environmental chemicals,” Science, 272, 1996, pp. 1489-1492. Arnold, S. F., M.K. Robinson, A.C. Notides, L.J. Guillette, and J.A. Mclachlan, “A yeast estrogen screen for examining the relative exposure of cells to natural and xenoestrogens,” Environ Health Perspect, 104, 1996, pp. 544-548. Astwood, W., “As assay method for progesterone based upon the decidual reaction in the rat,” Journal of Endocrinology, 1, 1939, pp. 49. Balaguer P., A. Joyeux, M.S. Denison, R. Vincent, B.E. Gillesby and T. Zacharewski, “Assessing the estrogenic and dioxin-like activities of chemicals and complex mixtures using in vitro recombinant receptor-reporter gene assays,” Canadian Journal of Physiology and Pharmacology, 74, 1996, pp. 216-222. Berman, E., and J. Laskey, “Altered steroidogenesis in whole-ovary and adrenal culture in cycling rats,” Reproductive Toxicology, 7, 1993, pp. 349-358. Briand P, and A.E. Lykkesfeldt, “Long-term cultivation of a human breast cancer cell line, MCF7, in chemically defined medium. Effect of estradiol,” Anticancer Res., 6, 1986, pp. 85-90. Brooks S.C., E.R. Locke, and H.D. Soule, “Estrogen receptor in a human cell line (MCF-7) from breast carcinoma,” Journal of Biological Chemistry, 248, 1973, pp. 6251-3. Brotons J. A., M.F. Olea-Serrano, M. Villalobos, V. Pedraza, N. Olea, “Xenoestrogens released from lacquer coating in food cans,” Environ Health Perspect., 103, 1995, pp. 608-613. 2 J - EDSTAC Final Report Chapter Five Appendices August 1998 Butler, W., W.L. Kirkland, T. Gargala, N. Goran, W.H. Kelsey, P. Berlinski, “Steriod stimulation of plasminogen activator production in a human breast cancer cell line (MCG-7),” Cancer Res., 43, 1983, pp. 1637-1641. Butler W.B., “Preparing nuclei from cells in monolayer cultures suitable for counting and for following synchronized cells through the cell cycle,” Analytical Biochemistry, 141, 1984, pp. 70-3. Chapin, R., M. Harris, M. Shelby, R. Smialowicz,V. Moser, S. Padilla, R. MacPhail, and S. Berone, “The effects of perinatal/juvenile pesticide exposure on adult CNS, Immune and reproductive function in rats,” The Toxicologist, pp. 30-52. Clark M., R.D. Cramer, D.M. Jones, D.E. Patterson, P.E. Simeroth, “Comparative Molecular Field Analysis (CoMFA), 2, Toward its use with 3D-Structural Databases,” Tetrahedron Comp Meth., 3, 1990, pp. 47-59. Conner, J., J. Cook, C. Craven, C. Van Pelt, J. and Obourn, “An in vivo battery for identifying endocrine modulators that are estrogenic or dopamine regulators,” Fundamental and Applied Toxicology, 33,1996, in print. Cramer R. D. I., D.E. Patterson, J.D. Bunce, “Comparative molecular field analysis (CoMFA), 1, Effect of shape on binding of steroids to carrier Proteins,” J Am Chem Soc., 110, 1988, pp. 5959-5967. Cummings, A., “Toxicological mechanisms of implantation failure,” Fundamental and Applied Toxicology, 15,1990, pp. 571-579. Cummings, A., and L. Gray, “Antifertility effect of methoxychlor in female rats: Dose- and time- dependent blockade of pregnancy,” Toxicology and Applied Pharmacolog, 97, 1989, pp. 454-462. Dell'Aquila M. L., D.A. Pigott, D.L. Bonaquist and E.V. Gaffney, “A factor from plasma-derived human serum that inhibits the growth of the mammary cell line MCF-7: characterization and purification,” Journal of the National Cancer Institute, 72, 1984, pp. 291-8. Desbrow, C., M. Waldock, D. Sheahan, M. Blackburn, E. Routledge, J. Sumpter, and G. Brighty, “The identification of compounds causing endocrine disruption in fish in UK rivers,” 17th Annual Society of Environmental Toxicology and Chemistry Abstract 190. Devleeschouwer N., N. Legros, N. Olea-Serrano, R. Paridaens and G. Leclercq, “Estrogen conjugates and serum factors mediating the estrogenic trophic effect on MCF-7 cell growth,” Cancer Research, 47, 1987, pp. 5883-7. Dodds, E., W. Lawson, and R. Noble, R., “Biological effects of the synthetic oestrogenic substance 4:4'-dihydroxy-I:B-diethylstilbene,” Lancet 139, 1938, pp. 627. Eisman J.A., T.J. Martin, I. MacIntyre, R.J. Frampton, J.M. Moseley and R. Whitehead R., “1,25- Dihydroxyvitamin D3 receptor in a cultured human breast cancer cell line (MCF 7 cells),” Biochemical & Biophysical Research Communications, 93, 1980, pp. 9-15. Fail, P, Pearce, S. Anderson, R. Tyl, and L. Gray, “Endocrine and reproductive toxicity of vinclozolin in male Long-Evans hooded rats,” The Toxicologist, 15, 1993, pp. 293. Gaido, K. W., L.S. Leonard, S. Lovell, J.C. Gould, D. Babai, C.J. Portier, D.P. McDonnell, “Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay,” Toxicol. Appl. Pharmacol, 1996. (submitted). 3 J - EDSTAC Final Report Chapter Five Appendices August 1998 Gaido, K.W., L. S. Leonard, S. Lovell, J.C. Gould, D. Babai, C.J. Portier, D.P. McDonnell, “Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay,” Toxicol. Appl. Pharmacol., 1996, (submitted). Gajdova, M., J. Jakubpvsky, and J. Valky, “Delayed effects of neonatal exposure to Tween 80 on female reproductive organs in rats,” Food and Chemical Toxicology, 31(3), 1993, pp. 183-190. Gellert, R. J., W. L. Heinrichs, and R. Swerdloff, “Effects of neonatally-administered DDT homologs on reproductive function in male and female rats,” Neuroendocrinology, 16, 1974, pp. 84-94. Gellert, R. J., Kepone, Mirex, Dieldrin and Aldrin, “Estrogenic activity and the induction of persistent vaginal estrus and anovulation in rats following neonatal treatment,” Environmental Research, 16, 1978a, pp. 131-138. Gellert, R. J., “Uterotrophic activity of polychlorinated biphenyls and induction of precocious reproductive aging in neonatally treated female rats,” Environ. Res., 16, 1978b, pp. 123- 130. Gellert, R. J. and C. Wilson, “Reproductive function in rats exposed prenatally to pesticides and polychlorinated biphenyls (PCB),” Environmental Research, 18, 1979, pp. 437-443. Glasser, S., R. Northcutt, F. Chytil, and C. Strott, “The influence of an antisteroidogenic drug (aminoglutethimide phosphate) on pregnancy maintenance,” Endocrinology, 90, 1972, pp. 1363-1370. Goldman, A. S., R.D. Eavey, M.K. Baker, “Production of male pseudohermaphroditism in rats by two new inhibitors of steroid 17I-hydroxylase and C17-20 lyase,” J. Endocrinology, 71, 1976, pp. 289-297. Goodman and Gillman's, “The Pharmacological basis of therapeutics,” Eighth Edition, MacMillian, 1990. Gorski, R. A., J.H. Gordon, J.E. Shryne, and A.M. Southam, “Evidence for a morphological sex difference within the medial preoptic area of the rat brain,” Brain Research, 148, 1978, pp. 333-346. Gray, L. E. Jr., “Neonatal chlordecone exposure alters behavioral sex differentiation in female hamsters,” Neurotoxicology, 3(2),
Load more

Recommended publications
  • OSPAR Background Document on Methoxychlor ______
    Hazardous Substances Series --------------------------------------------------------------------------------------------------------------------- Methoxychlor1 OSPAR Commission 2002 (2004 Update) 1 Secretariat’s note: A review statement on methoxychlor (Publication 352d/2008) was adopted in 2008, highlighting new developments since the adoption of the Background Document. OSPAR Commission, 2002: OSPAR Background Document on Methoxychlor _______________________________________________________________________________________________________ The Convention for the Protection of the Marine Environment of the North-East Atlantic (the “OSPAR Convention”) was opened for signature at the Ministerial Meeting of the former Oslo and Paris Commissions in Paris on 22 September 1992. The Convention entered into force on 25 March 1998. It has been ratified by Belgium, Denmark, Finland, France, Germany, Iceland, Ireland, Luxembourg, Netherlands, Norway, Portugal, Sweden, Switzerland and the United Kingdom and approved by the European Community and Spain. La Convention pour la protection du milieu marin de l'Atlantique du Nord-Est, dite Convention OSPAR, a été ouverte à la signature à la réunion ministérielle des anciennes Commissions d'Oslo et de Paris, à Paris le 22 septembre 1992. La Convention est entrée en vigueur le 25 mars 1998. La Convention a été ratifiée par l'Allemagne, la Belgique, le Danemark, la Finlande, la France, l’Irlande, l’Islande, le Luxembourg, la Norvège, les Pays-Bas, le Portugal, le Royaume-Uni de Grande Bretagne et d’Irlande du Nord, la Suède et la Suisse et approuvée par la Communauté européenne et l’Espagne. © OSPAR Commission, 2002. Permission may be granted by the publishers for the report to be wholly or partly reproduced in publications provided that the source of the extract is clearly indicated. © Commission OSPAR, 2002.
    [Show full text]
  • (A) Sources, Including As Appropriate (Provide Summary Information
    UNEP/POPS/POPRC.1/4 Format for submitting pursuant to Article 8 of the Stockholm Convention the information specified in Annex E of the Convention Introductory information Name of the submitting Party/observer NGO Observer: Pesticide Action Network on behalf of the International POPs Elimination Network (IPEN) Contact details Clare Butler Ellis PhD, M.Inst.P, C.Env. Pesticide Action Network UK [email protected] Joseph DiGangi, PhD Environmental Health Fund +001-312-566-0985 [email protected] Chemical name Chlordecone Chemical name: 1,1a,3,3a,4,5,5,5a,5b,6-decachloro-octahydro-1,3,4-metheno-2H- cyclobuta[cd]pentalen-2-one CAS=143-50-0 Common trade names: GC 1189, Kepone, Merex Synonyms: Chlordecone, Chlordecone Kepone, Decachloroketone, Decachlorooctahydro-1,3,4-metheno-2H-cyclobuta(cd)pentalen-2-one, Decachloropentacyclo(5.3.0.0.0.0 2,6,4,10,5,9)decane-3-one, Decachlorotetracyclodecanone decachlorooctahydro- , Date of submission 27 January 2006 (a) Sources, including as appropriate (provide summary information and relevant references) (i) Production data: Quantity 1 “Chlordecone is no longer produced commercially in the United States. Between 1951 and 1975, approximately 3.6 million pounds (1.6 million kg) of chlordecone were produced in the United States (Epstein 1978). During this period, Allied Chemical Annex E information on chlordecone 1 UNEP/POPS/POPRC.1/4 Company produced approximately 1.8 million pounds (816,500 kg) of chlordecone at plants in Claymont, Delaware; Marcus Hook, Pennsylvania and Hopewell, Virginia. In 1974, because of increasing demand for chlordecone and a need to use their facility in Hopewell, Virginia, for other purposes, Allied Chemical transferred its chlordecone manufacturing to Life Sciences Products Company (EPA 1978b).
    [Show full text]
  • Detection of Estrogen Receptor Endocrine Disruptor Potency of Commonly Used Organochlorine Pesticides Using the LUMI-CELL ER Bioassay
    DEVELOPMENTAL AND REPRODUCTIVE TOXICITY Detection of Estrogen Receptor Endocrine Disruptor Potency of Commonly Used Organochlorine Pesticides Using The LUMI-CELL ER Bioassay John D. Gordon1, Andrew C: Chu1, Michael D. Chu2, Michael S. Denison3, George C. Clark1 1Xenobiotic Detection Systems, Inc., 1601 E. Geer St., Suite S, Durham, NC 27704, USA 2Alta Analytical Perspectives, 2714 Exchange Drive, Wilmington, NC 28405, USA 3Dept. of Environmental Toxicology, Meyer Hall, Univ. of California, Davis; Davis, CA 95616 USA Introduction Organochlorine pesticides are found in many ecosystems worldwide as result of agricultural and industrial activities and exist as complex mixtures. The use of these organochlorine pesticides has resulted in the contamination of lakes and streams, and eventually the animal and human food chain. Many of these pesticides, such as pp ’-DDT, pp ’-DDE, Kepone, Vinclozolin, and Methoxychlor (a substitute for the banned DDT), have been described as putative estrogenic endocrine disruptors, and act by mimicking endogenous estrogen 1-3 . Estrogenic compounds can have a significant detrimental effect on the endocrine and reproductive systems of both human and other animal populations 4 . Previous studies have shown a strong association between several EDCs (17p-Estradiol, DES, Zeralanol, Zeralenone, Coumestrol, Genistein, Biochanin A, Diadzein, Naringenin, Tamoxifin) and estrogenic activity via uterotropic assay, cell height, gland number, increased lactoferrin, and a transcriptional activity assay using BG1Luc4E2 cells4 . Some other examples of the effects of these EDCs are: decreased reproductive success and feminization of males in several wildlife species; increased hypospadias along with reductions in sperm counts in men; increase in the incidence of human breast and prostate cancers; and endometriosis 3-5 .
    [Show full text]
  • Endocrine Disruptors
    Endocrine disruptors Afke Groen & Christine Neuhold The RECIPES project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824665 Authors Afke Groen, Maastricht University* Christine Neuhold, Maastricht University * currently works at the think tank Mr. Hans van Mierlo Stichting With thanks to our two anonymous interviewees Manuscript completed in April 2020 Document title WP2 Case study: Endocrine disruptors Work Package WP2 Document Type Deliverable Date 13 April 2020 Document Status Final version Acknowledgments & Disclaimer This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824665. Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use which might be made of the following information. The views expressed in this publication are the sole responsibility of the author and do not necessarily reflect the views of the European Commission. Reproduction and translation for non-commercial purposes are authorised, provided the source is acknowledged and the publisher is given prior notice and sent a copy. WP2 Case study: Endocrine disruptors i Abstract Endocrine disrupting chemicals (EDCs) are at the centre stage of a scientific and regulatory controversy. Given the complexities, ambiguities and particularly the uncertainties surrounding the hazards of EDCs, the precautionary principle is of utmost relevance to the case. Even the definition of EDCs remains much contested, as do the scientific processes and methods through which to identify them. On the one hand, there is considerable societal pressure to regulate ECDs ‘now’. On the other hand, this quick regulation is often impossible as the limited evidence available does not suffice in the context of traditional EU scientific risk assessment.
    [Show full text]
  • EPA Method 525.2
    METHOD 525.2 DETERMINATION OF ORGANIC COMPOUNDS IN DRINKING WATER BY LIQUID-SOLID EXTRACTION AND CAPILLARY COLUMN GAS CHROMATOGRAPHY/MASS SPECTROMETRY Revision 2.0 J.W. Eichelberger, T.D. Behymer, W.L. Budde - Method 525, Revision 1.0, 2.0, 2.1 (1988) J.W. Eichelberger, T.D. Behymer, and W.L. Budde - Method 525.1 Revision 2.2 (July 1991) J.W. Eichelberger, J.W. Munch, and J.A. Shoemaker Method 525.2 Revision 1.0 (February, 1994) J.W. Munch - Method 525.2, Revision 2.0 (1995) NATIONAL EXPOSURE RESEARCH LABORATORY OFFICE OF RESEARCH AND DEVELOPMENT U.S. ENVIRONMENTAL PROTECTION AGENCY CINCINNATI, OHIO 45268 525.2-1 METHOD 525.2 DETERMINATION OF ORGANIC COMPOUNDS IN DRINKING WATER BY LIQUID-SOLID EXTRACTION AND CAPILLARY COLUMN GAS CHROMATOGRAPHY/MASS SPECTROMETRY 1.0 SCOPE AND APPLICATION 1.1 This is a general purpose method that provides procedures for determination of organic compounds in finished drinking water, source water, or drinking water in any treatment stage. The method is applicable to a wide range of organic compounds that are efficiently partitioned from the water sample onto a C18 organic phase chemically bonded to a solid matrix in a disk or cartridge, and sufficiently volatile and thermally stable for gas chromatog-raphy. Single-laboratory accuracy and precision data have been determined with two instrument systems using both disks and cartridges for most of the following compounds: Chemical Abstract Services Analyte MW1 Registry Number Acenaphthylene 152 208-96-8 Alachlor 269 15972-60-8 Aldrin 362 309-00-2 Ametryn 227
    [Show full text]
  • December 12, 1995. Title
    AN ABSTRACT OF THE THESIS OF Sirinmas Intharapanith for the degree of Master of Science in Toxicology presented on December 12, 1995.Title:Effect of Xenoestrogen Exposure on The Expression of Cytocluome P450 Isoforms in Rainbow Trout Liver. Redacted for privacy Abstract approved: Donald R. Buhler Experimental evidence revealsthat xenoestrogens such asorganochlorine pesticides, pharmaceuticals, phenolic compounds and phytoestrogen exhibit reproductive effects on the health of human and wildlife populations. In rainbow trout, injection with 1713-estradiol represses expression of cytochrome P450s (CYP2K1, CYP2M1 and P450 LMC5) and reduces hepatic lauric acid hydroxylase activity. The aim of our study was to examine the effect on the regulation of rainbow trout P450s of four xenoestrogenic chemicals from the following categories:pesticides, pharmaceuticals, surfactants and phytoestrogens. Therefore, four chemicals, methoxychlor (20 mg/kg), diethylstilbestrol (15 mg/kg), 4-tert-octylphenol (25 and 50 mg/kg) and biochanin A (25 and 50 mg/kg) were injected (ip) on days 1,4 and 7 into one-year old juvenile rainbow trout using propylene glycol as vehicle. All fish were sacrificed on day 9.Plasma vitellogenin levels were measured by ELISA and used as an indicator of the estrogenic activity of the four chemicals. Plasma vitellogenin increased in all treated trout to varying degrees, ranging from high to low, in response to the test chemicals in the following order of decreasing of activities: diethylstilbestrol (15 mg/kg), 4-tert-octylphenol (50 mg/kg), 4-tert-octylphenol (25 mg/kg), biochanin A (50 mg/kg), biochanin A (25 mg/kg) and methoxychlor (20 mg/kg), respectively. As found upon treatment with estrogens, all four chemicals treated trout liver microsomes markedly repressed expression of P450's in liver microsomes from treated trout as measured by Western blots.Laurie acid hydroxylase activity also was greatly reduced in trout treated with all four chemicals.
    [Show full text]
  • Developmental Reprogramming of Reproductive and Metabolic Dysfunction in Sheep: Native Steroids Vs
    international journal of andrology ISSN 0105-6263 REVIEW ARTICLE Developmental reprogramming of reproductive and metabolic dysfunction in sheep: native steroids vs. environmental steroid receptor modulators V. Padmanabhan, H. N. Sarma, M. Savabieasfahani, T. L. Steckler and A. Veiga-Lopez Department of Pediatrics and the Reproductive Sciences Program, The University of Michigan, Ann Arbor, MI, USA Summary Keywords: The inappropriate programming of developing organ systems by exposure to bisphenol A, endocrine disrupting chemicals, excess native or environmental steroids, particularly the contamination of our foetal programming, infertility, insulin environment and our food sources with synthetic endocrine disrupting chemi- resistance, metabolic programming, cals that can interact with steroid receptors, is a major concern. Studies with methoxychlor, neuroendocrine, ovary native steroids have found that in utero exposure of sheep to excess testoster- Correspondence: one, an oestrogen precursor, results in low birth weight offspring and leads to Vasantha Padmanabhan, Room 1109, 300 N. an array of adult reproductive ⁄ metabolic deficits manifested as cycle defects, Ingalls Building, University of Michigan, Ann functional hyperandrogenism, neuroendocrine ⁄ ovarian defects, insulin resis- Arbor, MI 48109, USA. tance and hypertension. Furthermore, the severity of reproductive dysfunction E-mail: [email protected] is amplified by excess postnatal weight gain. The constellation of adult repro- ductive and metabolic dysfunction in prenatal testosterone-treated sheep is Received 18 August 2009; revised 25 October similar to features seen in women with polycystic ovary syndrome. Prenatal 2009; accepted 27 October 2009 dihydrotestosterone treatment failed to result in similar phenotype suggesting doi:10.1111/j.1365-2605.2009.01024.x that many effects of prenatal testosterone excess are likely facilitated via aroma- tization to oestradiol.
    [Show full text]
  • 1 of 3 GC+LC-USA
    Updated: 07/18/2016 1 of 3 GC+LC-USA Limit of Quantitation (LOQ): 0.010 mg/kg (ppm) Sample Types: Low Fat Content Samples Minimum Sample Size: 100 grams (~1/4 pound). Certain products require more for better sample representation. Instrument: GC-MS/MS and LC-MS/MS Turnaround: 24-48 hours Accreditation: Part of AGQ USA's ISO/IEC 17025 Accreditation Scope 4,4'-Dichlorobenzophenone Bupirimate Cyantraniliprole Diflufenican Abamectin Buprofezin Cyazofamid Dimethoate Acephate Butachlor Cycloate Dimethoate (Sum) Acequinocyl Butocarboxim Cycloxydim Dimethomorph Acetamiprid Butralin Cyflufenamid Diniconazole Acetochlor Cadusafos Cyfluthrin Dinocap Acrinathrin Captafol Cymoxanil Dinotefuran Alachlor Captan Cyproconazole Diphenylamine Aldicarb Captan (Sum) Cyprodinil Disulfoton Aldicarb (Sum) Carbaryl Cyromazine Disulfoton (Sum) Aldicarb-sulfone Carbofuran DDD-o,p Disulfoton-sulfone Aldicarb-sulfoxide Carbofuran-3-hydroxy DDD-p,p +DDT-o,p Disulfoton-sulfoxide Aldrin Carbophenothion DDE-o,p Ditalimfos Ametryn Carbosulfan DDE-p,p Diuron Amitraz Carboxine DDT (Sum) Dodemorph Atrazine Carfentrazone-ethyl DDT-p,p Dodine Azadirachtin Chinomethionat DEET Emamectin Benzoate Azamethiphos Chlorantraniliprole Deltamethrin Endosulfan (A+B+Sulf) Azinphos-ethyl Chlordane Demeton Endosulfan Alfa Azinphos-methyl Chlordane Trans Demeton-S-methyl-sulfone Endosulfan Beta Azoxystrobin Chlorfenapyr Desmedipham Endosulfan Sulfate Benalaxyl Chlorfenson Diafenturion Endrin Ben-Carb-TPM (Sum) Chlorfenvinphos Dialifos EPN Bendiocarb Chlorfluazuron Diazinon Epoxiconazole
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,486,374 B2 Tamarkin Et Al
    USOO8486374B2 (12) United States Patent (10) Patent No.: US 8,486,374 B2 Tamarkin et al. (45) Date of Patent: Jul. 16, 2013 (54) HYDROPHILIC, NON-AQUEOUS (56) References Cited PHARMACEUTICAL CARRIERS AND COMPOSITIONS AND USES U.S. PATENT DOCUMENTS 1,159,250 A 11/1915 Moulton 1,666,684 A 4, 1928 Carstens (75) Inventors: Dov Tamarkin, Maccabim (IL); Meir 1924,972 A 8, 1933 Beckert Eini, Ness Ziona (IL); Doron Friedman, 2,085,733. A T. 1937 Bird Karmei Yosef (IL); Alex Besonov, 2,390,921 A 12, 1945 Clark Rehovot (IL); David Schuz. Moshav 2,524,590 A 10, 1950 Boe Gimzu (IL); Tal Berman, Rishon 2,586.287 A 2/1952 Apperson 2,617,754 A 1 1/1952 Neely LeZiyyon (IL); Jorge Danziger, Rishom 2,767,712 A 10, 1956 Waterman LeZion (IL); Rita Keynan, Rehovot (IL); 2.968,628 A 1/1961 Reed Ella Zlatkis, Rehovot (IL) 3,004,894 A 10/1961 Johnson et al. 3,062,715 A 11/1962 Reese et al. 3,067,784. A 12/1962 Gorman (73) Assignee: Foamix Ltd., Rehovot (IL) 3,092.255. A 6, 1963 Hohman 3,092,555 A 6, 1963 Horn 3,141,821 A 7, 1964 Compeau (*) Notice: Subject to any disclaimer, the term of this 3,142,420 A 7/1964 Gawthrop patent is extended or adjusted under 35 3,144,386 A 8/1964 Brightenback U.S.C. 154(b) by 1180 days. 3,149,543 A 9, 1964 Naab 3,154,075 A 10, 1964 Weckesser 3,178,352 A 4, 1965 Erickson (21) Appl.
    [Show full text]
  • Exploring the Environmental Exposure to Methoxychlor, Α-HCH and Endosulfan–Sulfate Residues in Lake Naivasha (Kenya) Using a Multimedia Fate Modeling Approach
    International Journal of Environmental Research and Public Health Article Exploring the Environmental Exposure to Methoxychlor, α-HCH and Endosulfan–sulfate Residues in Lake Naivasha (Kenya) Using a Multimedia Fate Modeling Approach Yasser Abbasi * and Chris M. Mannaerts Department of Water Resources, Faculty of Geo-Information Science and Earth Observation, University of Twente, Hengelosestraat 99, 7514 AE Enschede, The Netherlands; [email protected] * Correspondence: [email protected] Received: 10 March 2020; Accepted: 13 April 2020; Published: 15 April 2020 Abstract: Distribution of pesticide residues in the environment and their transport to surface water bodies is one of the most important environmental challenges. Fate of pesticides in the complex environments, especially in aquatic phases such as lakes and rivers, is governed by the main properties of the contaminants and the environmental properties. In this study, a multimedia mass modeling approach using the Quantitative Water Air Sediment Interaction (QWASI) model was applied to explore the fate of organochlorine pesticide residues of methoxychlor, α-HCH and endosulfan–sulfate in the lake Naivasha (Kenya). The required physicochemical data of the pesticides such as molar mass, vapor pressure, air–water partitioning coefficient (KAW), solubility, and the Henry’s law constant were provided as the inputs of the model. The environment data also were collected using field measurements and taken from the literature. The sensitivity analysis of the model was applied using One At a Time (OAT) approach and calibrated using measured pesticide residues by passive sampling method. Finally, the calibrated model was used to estimate the fate and distribution of the pesticide residues in different media of the lake.
    [Show full text]
  • Mutagens and Reproductive Toxins Chemical Class Standard Operating Procedure
    1 Mutagens and Reproductive Toxins Chemical Class Standard Operating Procedure Mutagens and Reproductive Toxins H340 H341 H360 H361 H362 This SOP is not a substitute for hands-on training. Print a copy and insert into your laboratory SOP binder. Department: Chemistry Date SOP was written: Thursday, July 1, 2021 Date SOP was approved by PI/lab supervisor: Thursday, July 1, 2021 Name: F. Fischer Principal Investigator: Signature: ______________________________ Name: Matthew Rollings Internal Lab Safety Coordinator or Lab Manager: Lab Phone: 510.301.1058 Office Phone: 510.643.7205 Name: Felix Fischer Emergency Contact: Phone Number: 510.643.7205 Tan Hall 674, 675, 676, 679, 680, 683, 684 Location(s) covered by this SOP: Hildebrand Hall: D61, D32 1. Purpose This SOP covers the precautions and safe handling procedures for the use of Mutagens and Reproductive Toxins. For a list of Mutagens and Reproductive Toxins covered by this SOP and their use(s), see the “List of Chemicals”. Procedures described in Section 12 apply to all materials covered in this SOP. A change to the “List of Chemicals” does not constitute a change in the SOP requiring review or retraining. If you have questions concerning the applicability of any recommendation or requirement listed in this procedure, contact the Principal Investigator/Laboratory Supervisor or the campus Chemical Hygiene Officer at [email protected]. 2. Physical & Chemical Properties/Definition of Chemical Group Germ Cell Mutagenicity is a hazard class that is primarily concerned with chemicals that may cause mutations in the germ cell of humans that can be transmitted to the progeny. Rev.
    [Show full text]
  • Methoxychlor
    METHOXYCHLOR DRAFT RISK MANAGEMENT EVALUATION First Draft 9 April 2021 UNEP/POPS/POPRC.17/xxx Contents Executive Summary ............................................................................................................................................... 3 1. Introduction ...................................................................................................................................................... 4 1.1 Chemical identity of methoxychlor ......................................................................................................... 4 1.2 Production and uses ................................................................................................................................. 5 1.3 Conclusions of the POPs Review Committee regarding Annex E information .................................. 6 1.4 Data sources .............................................................................................................................................. 7 1.4.1 Overview of data submitted by Parties and observers............................................................ 7 1.4.2 Other data sources ..................................................................................................................... 7 1.5 Status of the chemical under International Conventions ..................................................................... 7 1.6 Any national or regional control actions taken ..................................................................................... 7 2. Summary of
    [Show full text]